FIS SB 390/585/1500 S Component A (Mortar)

Hazard statements (CLP)

H315, H317, H318, H335

Code

Statements

H315

Causes skin irritation

H317

May cause an allergic skin reaction

H318

Causes serious eye damage.

H335

May cause respiratory irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage

Hazard pictograms

GHS05 GHS07

Signal word

Danger

Contains

Hydroxypropyl methacrylate, portland cement

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H335 - May cause respiratory irritation.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear protective gloves, protective clothing/eye protection/face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII C o m p o n e n t portland cement (65997-15-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Hydroxypropyl methacrylate (27813-02-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin Irrit. 2 H315 Eye Dam. 1 H318 Skin Sens. 1 H317 STOT SE 3 H335 Full text of hazard classes, H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS05 GHS07 Signal word (CLP) : Danger Contains : Hydroxypropyl methacrylate, portland cement Hazard statements (CLP) : H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H335 - May cause respiratory irritation. Precautionary statements (CLP) : P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear protective gloves, protective clothing/eye protection/face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor. 2.3. Other hazards Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII C o m p o n e n t portland cement (65997-15-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Hydroxypropyl methacrylate (27813-02-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures